BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ikura Y. Transitions of histopathologic criteria for diagnosis of nonalcoholic fatty liver disease during the last three decades. World J Hepatol 2014; 6(12): 894-900 [PMID: 25544876 DOI: 10.4254/wjh.v6.i12.894]
URL: https://www.wjgnet.com/1948-5182/full/v6/i12/894.htm
Number Citing Articles
1
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
2
Wei Qiu, Guangyi Wang, Xiaodong Sun, Junfeng Ye, Feng Wei, Xiaoju Shi, Guoyue Lv. The involvement of cell surface nucleolin in the initiation of CCR6 signaling in human hepatocellular carcinomaMedical Oncology 2015; 32(3) doi: 10.1007/s12032-015-0530-1
3
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver DiseaseGastroenterology 2016; 150(8): 1811 doi: 10.1053/j.gastro.2016.03.008
4
Xiang Qiu, Dan-Hong Gao, Xiao Xiang, Yu-Fang Xiong, Teng-Shi Zhu, Lie-Gang Liu, Xiu-Fa Sun, Li-Ping Hao. Ameliorative effects of lutein on non-alcoholic fatty liver disease in ratsWorld Journal of Gastroenterology 2015; 21(26): 8061-8072 doi: 10.3748/wjg.v21.i26.8061
5
Karen C. M. Moraes, Jacques Montagne. Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic DiseasesFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.728407
6
N V Denisov, V B Grinevich, E V Chernetcova, L A Kornouchova, U A Kravchuk, S A Partsernyak, A N Mironenko. NON-ALCOHOLIC FATTY LIVER DISEASE AS A NEW COMPONENT OF THE METABOLIC SYNDROME IN THE LIGHT OF MODERN METHODS OF DIAGNOSISHERALD of North-Western State Medical University named after I.I. Mechnikov 2017; 9(1): 34 doi: 10.17816/mechnikov20179134-41
7
Dayun Liu, Yibiao Huang, Wenjuan Nie, Jiaxuan Zhang, Lei Deng. SMALF: miRNA-disease associations prediction based on stacked autoencoder and XGBoostBMC Bioinformatics 2021; 22(1) doi: 10.1186/s12859-021-04135-2
8
Alessandra Stacchiotti, Gaia Favero, Antonio Lavazza, Igor Golic, Marija Aleksic, Aleksandra Korac, Luigi Fabrizio Rodella, Rita Rezzani, Anna Alisi. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver DiseasePLOS ONE 2016; 11(1): e0148115 doi: 10.1371/journal.pone.0148115
9
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liverExpert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
10
Jitka Starekova, Diego Hernando, Perry J. Pickhardt, Scott B. Reeder. Quantification of Liver Fat Content with CT and MRI: State of the ArtRadiology 2021; 301(2): 250 doi: 10.1148/radiol.2021204288
11
Suzan Schwertheim, Julia Kälsch, Holger Jastrow, Christoph Matthias Schaefer, Sarah Theurer, Saskia Ting, Ali Canbay, Heiner Wedemeyer, Kurt Werner Schmid, Hideo Andreas Baba. Characterization of two types of intranuclear hepatocellular inclusions in NAFLDScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71646-y